We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guidance on Flow Cytometric Devices Gives Tips on Risk Analysis, Studies
Guidance on Flow Cytometric Devices Gives Tips on Risk Analysis, Studies
Premarket submissions for flow cytometry devices should include a description of quality controls to ensure the device performs accurately throughout its lifecycle, the FDA says. This should include each analytical parameter reported by the device, including fluorescence intensity measures, when relevant.